University of Ioannina
Εργαστηριακή διερεύνηση της αστάθειας του δορυφορικού DNA, της μεθυλίωσης και των γονιδίων στόχων, ως δείκτες νεοπλασιών στον καρκίνο του παχέος εντέρου
Abstract
dc:descriptionColorectal cancer develops as the result of a stepwise progression through several genetic and epigenetic alterations. Aberrant DNA methylation of CpG islands and subsequent low- or high-level DNA microsatellite instability is assumed to drive colon carcinogenesis through frameshift mutations in target genes implicated in the regulation of cell growth or cell survival. The aim of this study was the search of the “molecular signature” which accompanies the transformation of a normal tissue first to a polyp and then to an adenoma and cancer using as molecular markers the microsatellite instability phenotype, promoter DNA methylation and the mutations of certain target genes. DNA extracted from blood, normal tissue, and tissues from polyps, adenomas and colorectal cancer of patients undergoing colonoscopy (healthy individuals, polyp/adenoma patients and colorectal carcinoma patients) was used to assess the microsatellite instability (using the five Bethesda markers), the prevalence of aberrant DNA methylation of hMLH1, P16 and MGMT promoter, and the frameshift mutations of target genes (ΒΑΧ, IGFIIR, hMSH3, hMSH6, TGFβRII, EGFR and c-MYB). Moreover, a total genomic sequence analysis of the MMR genes hMLH1 and hMSH2 was performed in all MSI-Η phenotype patients. Microsatellite instability was found in 17% of all of our patients, and particularly in those with tubulovillous/villous polyps or cancer. hMLH1 or CDKN2A/p16 promoter methylation was present only in tissue samples in contrast to MGMT that was also found in the blood. The frequency of promoter methylation for each locus grows up in the polyp/adenoma/carcinoma sequence with MGMT showing the higher frequency in each group. All colorectal cancer patients showed promoter DNA methylation in at least one locus, suggesting a potentially crucial role of DNA methylation in the progression of colorectal cancer. TGFβRII and c-MYB genes were mutated in all patients showing the MSI-Η phenotype together with simultaneous promoter DNA methylation of the three genes. One known mutation and one new mutation were found at the MSH2 gene in 2 of our MSI-Η patients (1 patient with HNPCC syndrome and one other with villous adenoma). DNA methylation analysis of a panel of genes provided specific methylation profiles for adenomatous/tubular polyps, tubulovillous/villous polyps and colorectal cancer, supporting the use of these alterations as a possible early detection marker. Moreover, the MSI phenotype resulted in promoter DNA methylation of hMLH1 and MGMT driving colorectal carcinogenesis through frameshift mutations not only in coding but possibly also in intronic repetitive sequences showing regulatory function, as for example EGFR and c-MYB. Finally, the overall examination of the genetic and epigenetic background, together with the detection of the pathological mutation at hMSH2 gene, may give for our patients the possibility of a better chemotherapeutic prevention and possibly a useful prognostic marker.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Psofaki, Vasiliki
- Ψωφάκη, Βασιλική
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28156